Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 26, 2024; 12(33): 6629-6634
Published online Nov 26, 2024. doi: 10.12998/wjcc.v12.i33.6629
Infection with Listeria monocytogenes meningoencephalitis: A case report
Da-Zhen Xu, Quan-Hui Tan
Da-Zhen Xu, Department of Nursing, Shanghai Sixth People’s Hospital, Shanghai 200233, China
Quan-Hui Tan, Department of Infectious Disease, Shanghai Sixth People’s Hospital, Shanghai 200233, China
Author contributions: Xu DZ and Tan QH jointly collected the data and co-authored this paper. Both authors have read and approved the final version of the manuscript for publication.
Supported by National Natural Science Foundation of China, No. 82100631.
Informed consent statement: Informed consent for the publication of this article was obtained from the patient.
Conflict-of-interest statement: None of the authors have any conflict of interest to declare.
CARE Checklist (2016) statement: We have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Quan-Hui Tan, PhD, Academic Research, Department of Infectious Disease, Shanghai Sixth People’s Hospital, No. 600 Yishan Road, Xuhui District, Shanghai 200233, China. tanquanhui@sina.cn
Received: May 1, 2024
Revised: September 5, 2024
Accepted: September 9, 2024
Published online: November 26, 2024
Processing time: 149 Days and 3.4 Hours
Core Tip

Core Tip: Listeria meningitis is a potentially serious condition with a high associated mortality rate, making its early diagnosis crucial. In immunocompromised patients, active administration of first-line antibiotics can help achieve better clinical outcomes.